ATR
AptarGroup, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$127.41
−0.70%Year over year
Reported trailing growth
- Revenue
- +8.9%
- EBITDA
- +1.7%
- EBIT
- -6.4%
- EPS
- -5.2%
- Free cash flow
- -9.1%
- Operating cash flow
- -5.3%
Forward estimates
Based on analyst estimates
- Revenue
- +2.5%
- EBITDA
- +8.4%
- EPS
- +6.6%
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- +10.9%
- EBIT
- +10.5%
- Net income
- +18.0%
- EPS
- +17.7%
- Free cash flow
- +22.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026